Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 69.42B | 71.05B | 64.33B | 56.95B | 54.62B |
Gross Profit | 9.13B | 8.68B | 8.09B | 7.12B | 6.77B |
EBITDA | 2.96B | 2.58B | 971.00M | 483.00M | 164.00M |
Net Income | 1.78B | 1.53B | 650.00M | 261.00M | 398.00M |
Balance Sheet | |||||
Total Assets | 45.82B | 48.42B | 45.47B | 41.65B | 44.56B |
Cash, Cash Equivalents and Short-Term Investments | 6.54B | 6.39B | 4.36B | 4.42B | 6.07B |
Total Debt | 3.76B | 4.63B | 4.36B | 4.44B | 4.29B |
Total Liabilities | 24.28B | 27.42B | 26.15B | 23.56B | 24.37B |
Stockholders Equity | 21.37B | 20.85B | 19.16B | 17.96B | 20.08B |
Cash Flow | |||||
Free Cash Flow | 471.00M | 1.63B | 224.00M | -1.58B | 1.32B |
Operating Cash Flow | 624.00M | 1.92B | 563.00M | -1.18B | 1.68B |
Investing Cash Flow | 1.04B | 178.00M | -319.00M | -338.00M | 164.00M |
Financing Cash Flow | -1.57B | -121.00M | -332.00M | -205.00M | -238.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥11.09B | 10.64 | 1.89% | 19.52% | -9.23% | ||
77 Outperform | ¥9.83B | 5.43 | 3.64% | -2.82% | 18.67% | ||
76 Outperform | ¥10.67B | 12.38 | 2.57% | 16.82% | 52.74% | ||
73 Outperform | ¥12.29B | 10.20 | 2.99% | 2.61% | 9.37% | ||
66 Neutral | ¥8.74B | 8.41 | 3.73% | 5.00% | 25.91% | ||
64 Neutral | $10.95B | 16.10 | 8.81% | 1.99% | 2.59% | -16.41% | |
60 Neutral | ¥9.83B | 22.61 | 3.51% | -5.08% | -3.36% |